This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

OvaScience Appoints Fertility Pioneer Jamie Grifo M.D., Ph.D., To Clinical Advisory Board

OvaScienceSM, (NASDAQ: OVAS), a life sciences company focused on the discovery, development and commercialization of female fertility treatments, announced today the appointment of Jamie Grifo, M.D., Ph.D., of the New York University (NYU) Fertility Center and the  Division of Reproductive Endocrinology at the NYU School of Medicine, to its Clinical Advisory Board.

“Throughout his career, Dr. Grifo has been at the forefront of bringing the latest innovations in fertility to patients, such as pre-implantation genetic diagnosis,” said Michelle Dipp, Chief Executive Officer, OvaScience. “His research continues to drive major advances in the field and we look forward to his contributions to OvaScience.”

“As more women delay childbearing, which can result in decreased egg quality, there are a growing number of patients seeking fertility treatments that could benefit from new innovations in the field,” said Dr. Grifo. “OvaScience’s EggPC SM technology is unique in that it has the potential to improve egg quality and offer new possibilities for helping women build their own families.”

Dr. Grifo is renowned in reproductive medicine for his technical innovation and leadership. His team pioneered the first successful use of pre-implantation genetic diagnosis (PGD) in the U.S., a technique which has been used in the assisted reproduction of thousands of children worldwide. Dr. Grifo’s research also produced the NYU Vitrification Method, a standard of care at NYU Fertility Center since 2004. Additional research focuses on egg freezing and stem cells.

Dr. Grifo is the Program Director of the New York University (NYU) Fertility Center. Since 1995 he has been the Director of the Division of Reproductive Endocrinology at the NYU School of Medicine where he also holds the faculty appointment of Professor of Obstetrics and Gynecology. He received his M.D. and Ph.D. degrees at Case Western Reserve School of Medicine. A member of the American Society for Reproductive Medicine since 1989, Dr. Grifo has served on the Ethics Committee and is past president of the Society for Assisted Reproductive Technologies.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs